High-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of life

Professional, doctor. Scientist with microscope

Patients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than patients who received the previous standard-of-care treatment with either ipilimumab or high-dose interferon.

Study shows link between vaping and risk of caries

Previous article

The best Black Friday Beats deals live in the UK

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News